These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1529662)

  • 1. The appearance in thyroidectomized mice of immunoglobulins that bind TSH and stimulate FRTL-5 thyrocytes.
    Gafny M; Ben-David C; Sirkis N; Gordon A; Gross J
    Acta Endocrinol (Copenh); 1992 Aug; 127(2):161-7. PubMed ID: 1529662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Balb/C mice immunized with either xenogeneic or syngeneic TSH produce immunoglobulins with anti-TSH and thyroid-stimulating activities.
    Ben-David C; Gafny M; Sirkis N; Gordon A; Gross J
    Acta Endocrinol (Copenh); 1991 Nov; 125(5):532-7. PubMed ID: 1759542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
    Hill BL; Erlanger BF
    Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous measurement of TSH-binding inhibitor immunoglobulin and thyroid stimulating autoantibody activities using cultured FRTL-5 cells in patients with untreated Graves' disease.
    Lu C; Kasagi K; Hidaka A; Hatabu H; Iida Y; Konishi J
    Acta Endocrinol (Copenh); 1990 Sep; 123(3):282-90. PubMed ID: 1978457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of thyrotropin-induced iodide uptake in FRTL-5 cells by immunoglobulins containing blocking thyrotropin-receptor antibodies under NaCl-depleted conditions.
    Takeuchi R; Kasagi K; Hidaka A; Miyamoto S; Misaki T; Iida Y; Konishi J
    Eur J Endocrinol; 1995 Jan; 132(1):109-17. PubMed ID: 7850004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of thyrotropin-stimulated iodide uptake in FRTL-5 thyroid cells by crude immunoglobulin fractions from patients with goitrous and atrophic autoimmune thyroiditis.
    Tokuda Y; Kasagi K; Iida Y; Hatabu H; Misaki T; Arai K; Endo K; Konishi J
    J Clin Endocrinol Metab; 1988 Aug; 67(2):251-8. PubMed ID: 2899088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graves' IgG stimulation of iodide uptake in FRTL-5 rat thyroid cells: a clinical assay complementing FRTL-5 assays measuring adenylate cyclase and growth-stimulating antibodies in autoimmune thyroid disease.
    Marcocci C; Valente WA; Pinchera A; Aloj SM; Kohn LD; Grollman EF
    J Endocrinol Invest; 1983 Dec; 6(6):463-71. PubMed ID: 6689493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of thyroid stimulating activities measured by cyclic AMP production, those by radioiodine uptake in FRTL-5 cells and TSH-binding inhibitory activities in patients with hyperthyroid and euthyroid Graves' diseases.
    Kasagi K; Hatabu H; Tokuda Y; Arai K; Iida Y; Konishi J
    Acta Endocrinol (Copenh); 1988 Mar; 117(3):365-72. PubMed ID: 2898192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
    Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of intercellular adhesion molecule-1 expression in human thyroid cells in vitro and human thyroid tissue transplanted to the nude mouse in vivo: role of Graves' immunoglobulins and human thyrotropin receptor.
    Hoermann R; Spitzweg C; Poertl S; Mann K; Heufelder AE; Schumm-Draeger PM
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2048-55. PubMed ID: 9215271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xenogeneic thyroid-stimulating hormone-like activity of the human natural anti-Gal antibody. Interaction of anti-Gal with porcine thyrocytes and with recombinant human thyroid-stimulating hormone receptors expressed on mouse cells.
    Winand RJ; Anaraki F; Etienne-Decerf J; Galili U
    J Immunol; 1993 Oct; 151(7):3923-34. PubMed ID: 8104224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of nonionic polymers on thyroid stimulation and TSH receptor binding by the human monoclonal TSH receptor autoantibody M22.
    Ochi Y; Hamazu M; Kajita Y; Hachiya T; Miyata T; Barrett C; Smith BR
    Thyroid; 2009 Jan; 19(1):47-52. PubMed ID: 18976151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay.
    Vitti P; Rotella CM; Valente WA; Cohen J; Aloj SM; Laccetti P; Ambesi-Impiombato FS; Grollman EF; Pinchera A; Toccafondi R; Kohn LD
    J Clin Endocrinol Metab; 1983 Oct; 57(4):782-91. PubMed ID: 6136523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins.
    Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH
    Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulated iodide uptake in FRTL-5 cells preincubated with Graves' immunoglobulins in NaCl-free medium: a sensitive assay for thyroid-stimulating antibodies.
    Hidaka A; Kasagi K; Takeuchi R; Iida Y; Misaki T; Grollman EF; Konishi J
    Thyroid; 1994; 4(1):31-6. PubMed ID: 7914446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and specificities of labeled thyrotropic hormone (TSH) binding immunoglobulins (LTB-Igs) in patients with Graves' disease and other thyroid disorders.
    Akamizu T; Mori T; Ishii H; Yokota T; Nakamura H; Imura H
    Jpn J Med; 1986 Feb; 25(1):13-9. PubMed ID: 3754912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells.
    Kishihara M; Nakao Y; Baba Y; Kobayashi N; Matsukura S; Kuma K; Fujita T
    J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
    Heyma P; Harrison LC
    J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin dependent and independent thyroid cell lines selected from FRTL-5 derived tumors grown in nude mice.
    Ossendorp FA; Bruning PF; Schuuring EM; Van Den Brink JA; van der Heide D; De Vijlder JJ; De Bruin TW
    Endocrinology; 1990 Jul; 127(1):419-30. PubMed ID: 1694496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.